Cancer preventive
reagent trans-resveratrol is intracellularly biotransformed to different metabolites. However, it is still unclear whether
trans-resveratrol exerts its
biological effects directly or through its metabolite(s). This issue was addressed here by identifying the metabolic pattern and the bioactive form of
resveratrol in a
resveratrol-sensitive human
medulloblastoma cell line, UW228-3. The cell lysates and condition media of UW228-3 cells with or without 100 microM
resveratrol treatment were analyzed by HPLC and LC/MS which revealed (1) that
resveratrol was chemically unstable and the spontaneous generation of
cis-resveratrol reduced
resveratrol's anti-
medulloblastoma efficacy and (2) that
resveratrol monosulfate was the major metabolite of the cells. To identify the bioactive form of
resveratrol, a mixture-containing approximately half fraction of
resveratrol monosulfate was prepared by incubating
trans-resveratrol with freshly prepared rat brain lysates.
Medulloblastoma cells treated by 100 microM of this mixture showed attenuated cell crisis. The overall levels of the three brain-associated
sulfotransferases (SULT1A1, 1C2 and 4A1) were low in
medulloblastoma cells in vivo and in vitro in comparison with that in human noncancerous and rat normal cerebella;
resveratrol could more or less up-regulate the production of these
enzymes in UW228-3 cells but their overall level was still lower than that in normal cerebellum tissue. Our study thus demonstrated for the first time that
trans-resveratrol is the bioactive form in
medulloblastoma cells in which the expression of brain-associated SULTs was down-regulated, resulting in the increased intracellular bioavailability and anti-
medulloblastoma efficacy of
trans-resveratrol.